The Clinical and Cost Effectiveness of Apremilast for Treating Active Psoriatic Arthritis: A Critique of the Evidence

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1101–1110
Number of pages10
JournalPharmacoeconomics.
Volume34
Issue number11
Early online date8 Jun 2016
DOIs
Publication statusE-pub ahead of print - 8 Jun 2016

Bibliographical note

© Springer International Publishing Switzerland 2016. This is an author-produced version of the published paper. Uploaded in accordance with the publisher’s self-archiving policy. Further copying may not be permitted; contact the publisher for details.

Cite this